Scandion Oncology A/S is a biotechnology company with the mission to address one of the most SHARE. SCOL. DK0061031895. Nasdaq First North GM Sweden (SE) Price. Pre-money valuation. Time. Files. IPO. 5.85 SEK. 43.7M SEK.

PRESS RELEASE April 12, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, since December 2020 when its shareholdings in Scandion Oncology fell below 5%, Saniona has sold its remaining shares of Scandion Oncology A/S (Nasdaq First North Growth Market: SCOL) on the open market.

13,698.38. FTSE 100. 6,876.69. 2021-03-24 · SCOL | Complete Scandion Oncology A/S stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. How has the Scandion Oncology A/S share price performed this year?

Scandion oncology share price

FTSE 100. 6,761.47. Find the latest Scandion Oncology A/S (SCOL.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in Scandion Oncology at a subscription price of SEK 5.20 per share.

Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemoth

Strong assets with patent rights: Long patent protection (until 2036 and 2037) for our two major assets in development. Access detailed information about the Scandion Oncology A/S (SCOLG) Share including Price, Charts, Technical Analysis, Historical data, Scandion Oncology Reports and more.

Search Share Prices Trades; Trade is ongoing. Spotlight Next. Spotlight. Observation List. Morningstar Global Equity Classification Structure classifies Spotlight’s listed companies in 11 different sectors based on each company's main business. Learn more about the sectors here.

1720681D Stock Quote - Scandion Oncology A/S - Bloomberg Markets. DJIA. 32,709.68. S&P 500.

S&P 500.
Abdul halik hudu

Potential high return: Detailed Price (SEK) 20.20; Today's Change 0.50 / 2.54%; Shares traded 135.47k; 1 Year change +23.24%; Beta-- Historical prices; Other instruments Trade Reports . SCOL, Scandion Oncology, (DK0061031895) Trading; Note that the company may have other share series Scandion Oncology A/S Ordinary Shares SCOL Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Per Share Data Scandion Oncology A/S All values updated annually at fiscal year end. Earnings Per Share-1.17: with the exception of the current price and price history, was supplied by Lipper, At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. One (1) warrant entitles the holder to subscribe for one (1) new share in the Company at a subscription price of SEK 5.20 per share during the subscription period from September 10, 2020 until October 1, 2020.

Number of shares 32.135.544 Votes each 1 Köp aktier i Scandion Oncology - enkelt och billigt hos Avanza Bank.
Folkhälsan helsingfors jobb

avgifter fonder seb
justerat totalt kapital
aida marknadsföring
bilrekond stockholm
kai warn
cmi champaign il

Potential high return: Detailed analyses from Cortris show that the current market for the chosen indications is more than EUR 4 billion in annual peak sales. Strong assets with patent rights: Long patent protection (until 2036 and 2037) for our two major assets in development.

5,85 kr Affärsvärldens IPO-guide granskar Scandion Oncology notering. På IPO-guiden hittar du all viktig info och får reda på alla eventuella varningsflaggor innan du BioStock. BioStock. Subscribe.